Anti-NMDAR Encephalitis: Clinical Trials

1 trial for Anti-NMDAR Encephalitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Anti-NMDAR Encephalitis: new trials by email Literature Review of Anti-NMDAR Encephalitis trials Research Report on Anti-NMDAR Encephalitis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immunoadsorption Therapy in Managing NMDAR Antibodies Encephalitis
IA session, Rituximab - Anti-NMDAR Encephalitis
Phase 2CompletedAssistance Publique - Hôpitaux de Paris202021-06-232026-08-10

Narrower conditions

Anti-N-Methyl-D-Aspartate Receptor Encephalitis (1)

Broader conditions

Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Encephalitis (1)  ·  Immune System Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Nervous System Diseases (1)  ·  Nervous System Neoplasms (1)  ·  Neurodegenerative Diseases (1)  ·  Neuroinflammatory Diseases (1)  ·  Paraneoplastic Syndromes (1)  ·  Paraneoplastic Syndromes, Nervous System (1)

Interventions

Rituximab (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)

Countries

France (1)